(2024)
Bipolar disorder and the risk of cardiometabolic diseases, heart failure, and all-cause mortality: a population-based matched cohort study in South Korea.
SCIENTIFIC REPORTS.
14,
1
(2024)
Psychotic Disorders and the Risk of Type 2 Diabetes, Atherosclerotic Cardiovascular Diseases, and All-Cause Mortality: A Population-Based Matched Cohort Study.
DIABETES & METABOLISM JOURNAL.
-,
-
(2024)
Association between total cholesterol levels and all-cause mortality among newly diagnosed patients with cancer.
SCIENTIFIC REPORTS.
14,
1
(2024)
Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.
690,
-
(2023)
Increased risk of incident mental disorders in adults with new-onset type 1 diabetes diagnosed after the age of 19: a nationwide cohort study.
DIABETES & METABOLISM.
50,
1
(2023)
Depression, antidepressant use, and the risk of type 2 diabetes: a nationally representative cohort study.
FRONTIERS IN PSYCHIATRY.
14,
(2023)
Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Low Household Income Status and Death from Pneumonia in People with Type 2 Diabetes Mellitus: A Nationwide Study.
DIABETES & METABOLISM JOURNAL.
47,
5
(2023)
Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD.
SCIENTIFIC REPORTS.
13,
1
(2023)
Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study.
FRONTIERS IN ENDOCRINOLOGY.
14,
(2023)
An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial.
DIABETES CARE.
46,
5
(2023)
Association of body weight change with all-cause and cause-specific mortality: A nationwide population-based study.
DIABETES RESEARCH AND CLINICAL PRACTICE.
199,
(2023)
Low Skeletal Muscle Mass Accompanied by Abdominal Obesity Additively Increases the Risk of Incident Type 2 Diabetes.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM.
108,
5
(2023)
Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019.
DIABETES & METABOLISM JOURNAL.
47,
2
(2023)
Extracellular Vesicles Derived from Three-Dimensional-Cultured Human Umbilical Cord Blood Mesenchymal Stem Cells Prevent Inflammation and Dedifferentiation in Pancreatic Islets.
STEM CELLS INTERNATIONAL.
2023,
(2023)
MAFLD and NAFLD in the prediction of incident chronic kidney disease.
SCIENTIFIC REPORTS.
13,
1
(2023)
Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma.
AMERICAN JOURNAL OF CANCER RESEARCH.
13,
5
(2022)
The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: A nationwide cohort study.
DIABETES RESEARCH AND CLINICAL PRACTICE.
194,
-
(2022)
The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study.
CARDIOVASCULAR DIABETOLOGY.
21,
1
(2022)
A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well- Controlled Type 1 Diabetes Mellitus.
DIABETES & METABOLISM JOURNAL.
46,
6
단행본
(2023)
당뇨병의 정석.
(주)상식문화.
공동
(2023)
연속혈당측정을 이용한 혈당 조절 길잡이(인슐린 펌프/자동 인슐린 주입 편).
도서출판 마루.
공동
학술회의논문
(2023)
The emergence of SGLT2 inhibitor and Enavogliflozin's first step.
2nd KDA-Asia Pacific region Webinar on the Recent Treatment of Diabetes 2023.
대한민국
(2023)
CGMS+PUMP: 인공췌장 당뇨병 치료의 대안이 될 수 있나?.
세브란스병원 당뇨병 연수강좌.
대한민국
(2023)
Promoting Healthy Muscle and Liver Metabolism.
ICOMES 2023.
대한민국
(2023)
당뇨병의 이해와 최신경향.
내분비·신장계 간호사 보수교육 강의.
대한민국
(2023)
Artificial Pancreas.
연세대학교 대학원 의과학과 23-1학기 '당뇨병학' 강의.
대한민국
(2023)
당뇨병의 약물치료 전략.
2023년도 대한신경과학회 춘계 전문의 평생교육.
대한민국
